Jeffrey Yordon Insider Profile
4 Followers
Jeffrey Yordon, former Director at Sagent Pharm, holds 245.94K shares in Athenex (Ticker: ATNXQ), holds 686.01K shares in Sagent Pharm (Ticker: SGNT). Most recently, Jeffrey Yordon Bought ― shares of Athenex on Mar 12, 2020 for an estimated value of $81.40K.
Jeffrey Yordon's Trading History
| ATNXQAthenex | Mar 12, 2020 | ― | Informative Buy | 81.40K | $3.69K | |
| SGNTSagent Pharm | Apr 01, 2015 | ― | Uninformative Sell | ― | $14.93M |
You May Also Like
Jeffrey Yordon insider profile FAQ
What is the percentage of profitable transactions made by Jeffrey Yordon?
The percentage of profitable transactions made by Jeffrey Yordon is 33%.
What is the average return per transaction made by Jeffrey Yordon?
The average return per transaction made by Jeffrey Yordon is -14.70%.
What stocks does Jeffrey Yordon hold?
Jeffrey Yordon holds: SGNT, ATNXQ stocks.
What was Jeffrey Yordon’s latest transaction?
Jeffrey Yordon’s latest transaction was an Informative Buy of $81.40K.
What was Jeffrey Yordon's most profitable transaction?
Jeffrey Yordon’s most profitable transaction was an Informative Buy of ATNXQ stock on November 14, 2018. The return on the trade was 9.60%.
What is Jeffrey Yordon's role in Sagent Pharm?
Jeffrey Yordon's role in Sagent Pharm is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.
